Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Allylestrenol

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,862Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Approves Vtama Cream for Atopic Dermatitis in Adults
    FDA Approves Vtama Cream for Atopic Dermatitis in Adults

    18 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241216414255/en

    BUSINESSWIRE
    18 Dec 2024
    Share Share
    FDA Review Update on VTAMA® (Tapinarof) for Atopic Dermatitis
    FDA Review Update on VTAMA® (Tapinarof) for Atopic Dermatitis

    05 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241105332994/en

    BUSINESSWIRE
    05 Nov 2024
    Share Share
    GE HealthCare reports third quarter 2024 financial results
    GE HealthCare reports third quarter 2024 financial results

    30 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241029247090/en

    BUSINESSWIRE
    30 Oct 2024
    Share Share
    Organon Acquires Dermavant, Including VTAMA® (tapinarof) Cream
    Organon Acquires Dermavant, Including VTAMA® (tapinarof) Cream

    28 Oct 2024

    // #N/A

    https://www.globenewswire.com/news-release/2024/10/28/2970142/34323/en/Organon-Completes-Acquisition-of-Dermavant-including-Innovative-Dermatologic-Therapy-VTAMA-tapinarof-Cream-1.html

    #N/A
    28 Oct 2024
    Share Share
    Organon Acquires Dermavant, Including VTAMA® Cream
    Organon Acquires Dermavant, Including VTAMA® Cream

    28 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241028071253/en

    BUSINESSWIRE
    28 Oct 2024
    Share Share
    Organon To Report Q3 2024 Results October 31
    Organon To Report Q3 2024 Results October 31

    09 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241009583391/en

    BUSINESSWIRE
    09 Oct 2024
    Share Share